
The investigational combination opioid from Ensysce Biosciences is designed to deter abuse as well as prevent accidental or intentional overdose, the company said.

The investigational combination opioid from Ensysce Biosciences is designed to deter abuse as well as prevent accidental or intentional overdose, the company said.

Heart disease has been the primary cause of death in the US for the last century, and yet 51% of adults do not recognize the fact.

Already high rates of readmission and mortality at 30 days rose significantly higher at 90 days, according to this National Readmissions Database review.

Your daily dose of the clinical news you may have missed.

Unplanned emergency service and medication utilization make up the majority of costs of IBD care, reported researchers.

Dupilumab is the first agent approved to treat EoE in this vulnerable pediatric population.

Which medications are most effective for acute migraine management? A recent study assessed which ones appeared to work best based on reported patient experience.

Among more than 1.5 million persons hospitalized for COVID-19, a history of Crohn disease or ulcerative colitis significantly increased risk for poor outcomes.

Your daily dose of the clinical news you may have missed.

Survey findings presented at the Crohn’s & Colitis Congress suggest a need for education among some health care specialists about the clinical presentation of ulcerative colitis.

The effect of vagus nerve stimulation persons with narcolepsy revealed a specific, notable improvement in daytime sleepiness in a novel open-label study.

"A meaningful percentage" of individuals with Crohn disease are treated during maintenance with biologic doses ≥20%higher than recommended in FDA labeling.

Reports of migraine-related stigma were common in a recent population-based study, with nearly one-third reporting the experience often/very often.

Gabapentinoid use increased from 4.0% of the population reporting use of the medication in 2015 to 4.7% in 2021, according to new data.

Your daily dose of the clinical news you may have missed.

Adolescents with overweight or obesity and baseline HbA1c 6.3%-6.4% were at 72-fold greater risk for T2D than those with HbA1c of 5.5%, a new cohort study finds.
A 10-second check of your GI IQ.

Targeting "impermissible" barriers created to no-cost contraception required by the ACA, the HHS guidance follows the Biden-Harris June 2023 Executive Order on the issue.

Findings showed a high incidence of outpatient Clostridioides difficile infection despite a low rate of testing.

When does management of Crohn disease warrant assessment of C-reactive protein and fecal calprotectin and when is endoscopy indicated? Test your IBD IQ.